Wiggin
Firm overview:
Specialist IP firm Wiggin offers high-quality patent litigation and prosecution services alongside robust online enforcement capabilities. The patent team assists clients in a wide range of industries, such as electronics, engineering, software, technology (including artificial intelligence and blockchain), financial services, medical devices, biotechnology, and consumer goods. The firm emphasises partner-led work, guiding clients on strategic issues and handling sophisticated patent matters.
Team overview:
Head of IP Sarah Ashby is described by a peer as an “outstanding IP litigator”; “she has a razor-sharp legal brain, but is still very commercial and client focused. These qualities, together with her determination in litigation to get the best results for her clients, mean that she has a great success record”. Ashby is president of AIPPI UK, as well as holding positions on two of the organisation’s international committees.
Experienced IP litigator Priya Nagpal joined the team in May 2026, bringing over two decades in technology-related disputes. She specialises in complex, multi-jurisdictional disputes involving innovations in areas such as medical devices, software, and big data.
Key matters:
- PW: Multi-patent automotive infringement litigation
The firm represents German automotive engineering company BPW in a series of UK patent infringement actions involving automotive technologies, including matters before the Patents Court and under the Shorter Trials Scheme.
- Laboratorios León Farma: Supplementary Protection Certificate appeal
Wiggin represents Spanish pharmaceutical company Laboratorios León Farma in a High Court appeal over the refusal of a supplementary protection certificate (SPC) for its oral contraceptive product Slynd, concerning the interpretation of Article 3 of the SPC Regulation.
- Halozyme: Supplementary Protection Certificate appeal for biologic therapies
The team represented Halozyme in its appeal against a UKIPO decision refusing SPCs for combination biologic therapies incorporating recombinant human hyaluronidase.
Clients:
BPW, Entain, Halozyme, Laboratorios León Farma, Permavent
